Replimune (REPL) Operating Income (2017 - 2026)
Replimune (REPL) reported Operating Income of -$56.28 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$84.29 million a year earlier.
Powered by 
Analysis
Replimune (REPL) Operating Income (2017 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Replimune's Operating Income came in at -$269.73 million; for FY2026 (ended Mar 31, 2026), it was -$319.92 million.
- By fiscal year, Operating Income came in at -$261.63 million in FY2025, -$234.77 million in FY2024, -$177.08 million in FY2023 and -$118.31 million in FY2022.
- The fiscal Q2 2027 figure ranks as the highest quarterly Operating Income since fiscal Q1 2024.
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at -$68.25 million (Q1 2027), -$73.34 million (Q4 2026) and -$71.87 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 12.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 5.59 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Replimune | 2.40 Bn | 1.35 Bn | - | -56.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -56.28 Mn |
| Jun 30, 2026 | -68.25 Mn |
| Mar 31, 2026 | -73.34 Mn |
| Dec 31, 2025 | -71.87 Mn |
| Sep 30, 2025 | -84.29 Mn |
| Jun 30, 2025 | -90.42 Mn |
| Mar 31, 2025 | -79.33 Mn |
| Dec 31, 2024 | -66.02 Mn |
| Sep 30, 2024 | -58.92 Mn |
| Jun 30, 2024 | -57.37 Mn |
| Mar 31, 2024 | -58.76 Mn |
| Dec 31, 2023 | -56.54 Mn |
| Sep 30, 2023 | -63.83 Mn |
| Jun 30, 2023 | -55.65 Mn |
| Mar 31, 2023 | -53.00 Mn |
| Dec 31, 2022 | -41.63 Mn |
| Sep 30, 2022 | -41.58 Mn |
| Jun 30, 2022 | -40.88 Mn |
| Mar 31, 2022 | -31.99 Mn |
| Dec 31, 2021 | -29.70 Mn |
API Access
Replimune Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();